These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 56050)

  • 1. Renin substrate infusions in hepatorenal syndrome.
    McCombs PR; Berkowitz HD; Miller LD; Rosato EF
    Surg Forum; 1975; 26():419-21. PubMed ID: 56050
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in the clearance of water and solutes caused by the reinfusion of ascitic ultrafiltrates in the chronic hepatorenal syndrome].
    Ruggieri G; Spinelli C; Valeri L; Romano M
    Recenti Prog Med; 1980 Mar; 68(3):293-301. PubMed ID: 7027378
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of hemosorption on the blood levels of certain hormones in patients with pancreonecrosis and the hepatorenal syndrome].
    Riabov GA; Pospelov VV; Semenov VN; Bunin VM; Emtsov IuG
    Anesteziol Reanimatol; 1982; (3):35-7. PubMed ID: 7114564
    [No Abstract]   [Full Text] [Related]  

  • 4. Significance of altered renin substrate in the hepatorenal syndrome.
    Berkowitz HD; Galvin C; Miller LD
    Surg Forum; 1972; 23(0):342-3. PubMed ID: 4671111
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolonged hemoperfusion and hemodialysis in management of hepatic failure and hepatorenal syndrome.
    Krumlovsky FA; del Greco F; Niederman M
    Trans Am Soc Artif Intern Organs; 1978; 24():235-8. PubMed ID: 716004
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current therapeutic prospects in the hepatorenal syndrome].
    Campanacci L
    G Clin Med; 1975; 56(9-10):330-44. PubMed ID: 1228050
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnosis and therapy of the hepatorenal syndrome: a tentative classification.
    Dodsworth J; James JH; Cummings MG; Fischer JE
    Surg Forum; 1973; 24():396-7. PubMed ID: 4806037
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Renin substrate depletion in hepatorenal syndrome.
    Berkowitz HD; Miller LD; Rosato EF
    N Engl J Med; 1974 Feb; 290(8):461. PubMed ID: 4811028
    [No Abstract]   [Full Text] [Related]  

  • 9. [Indication for fresh blood transfusion].
    Seidl S
    Dtsch Med Wochenschr; 1969 Feb; 94(8):388-90. PubMed ID: 5763801
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatorenal syndrome. A review.
    Altman KA
    Am J Gastroenterol; 1968 May; 49(5):436-9. PubMed ID: 4297522
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined liver-kidney transplantation in children: indications and outcome.
    Sutherland SM; Alexander SR; Sarwal MM; Berquist WE; Concepcion W
    Pediatr Transplant; 2008 Dec; 12(8):835-46. PubMed ID: 19000066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to dopamine hydrochloride in the hepatorenal syndrome.
    Bennett WM; Keeffe E; Melnyk C; Mahler D; Rösch J; Porter GA
    Arch Intern Med; 1975 Jul; 135(7):964-71. PubMed ID: 1156055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatopulmonary syndrome.
    Krowka MJ
    Transplant Proc; 1993 Apr; 25(2):1746-7. PubMed ID: 8470149
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical use of a 10 percent solution of placental albumin].
    Mel'nik AK; Loginskiĭ VE; Monastyrskiĭ VA; Mindiuk MV
    Probl Gematol Pereliv Krovi; 1971 Jun; 16(6):7-11. PubMed ID: 5119069
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatorenal syndrome in neonates.
    Amir J; Dinari G; Zelikovic I; Wilunski E
    Helv Paediatr Acta; 1984 May; 39(2):167-9. PubMed ID: 6543840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatorenal syndrome (a review of the literature)].
    Makovetskaia GA; Munina LN; Soshnikova MA; Kryshkovets DV
    Vopr Okhr Materin Det; 1978 Mar; 23(3):46-9. PubMed ID: 347708
    [No Abstract]   [Full Text] [Related]  

  • 17. Deranged renal function in liver disease.
    Epstien M
    Contrib Nephrol; 1977; 7():250-71. PubMed ID: 330107
    [No Abstract]   [Full Text] [Related]  

  • 18. [Gene therapy: its contributions to liver and kidney diseases].
    Mazzolini G; Ruiz J; Qian C; Prieto J
    Nefrologia; 2001; 21 Suppl 1():17-23. PubMed ID: 11382095
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical use of an association of liver antitoxic fraction and cyanocobalamine in high doses in the therapy of hepatorenal diseases].
    GIROLAMI M; CAPOCACCIA L; CHECCHI E
    Clin Ter; 1962 Jan; 22():105-20. PubMed ID: 13898928
    [No Abstract]   [Full Text] [Related]  

  • 20. The hepato-renal syndrome--a review.
    Pimstone NR
    S Afr J Surg; 1976 Mar; 14(1):27-30. PubMed ID: 1273704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.